CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
Cystic fibrosis (CF) is a lethal inherited disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene, which result in impairment of CFTR mRNA and protein expression, function, stability or a combination of these. Although CF leads to multifaceted clinical manifestations,...
Saved in:
Main Author: | Miquéias Lopes-Pacheco (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CFTR modulators: Shedding light on precision medicine for cystic fibrosis
by: Miquéias Lopes-Pacheco
Published: (2016) -
Precision Medicine Based on CFTR Genotype for People with Cystic Fibrosis
by: Haq I, et al.
Published: (2022) -
Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis
by: Mafalda Bacalhau, et al.
Published: (2023) -
The Exocrine Pancreas in Cystic Fibrosis in the Era of CFTR Modulation: A Mini Review
by: Isabelle R. McKay, et al.
Published: (2022) -
Nutritional impact of CFTR modulators in children with cystic fibrosis
by: Margaux Gaschignard, et al.
Published: (2023)